Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision Without Change of a Previously Approved Collection Recordkeeping for Electronic Prescriptions for Controlled Substances, 93348-93349 [2024-27683]

Download as PDF 93348 Federal Register / Vol. 89, No. 228 / Tuesday, November 26, 2024 / Notices The company plans to bulk manufacture the listed controlled substances to be used in analytical testing. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2024–27693 Filed 11–25–24; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1117–0049] Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision Without Change of a Previously Approved Collection Recordkeeping for Electronic Prescriptions for Controlled Substances Drug Enforcement Administration, Department of Justice. ACTION: 60-Day notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until January 27, 2025. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Heather E. Achbach, Regulatory Drafting and Policy Support Section, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 776–3882; Email: SUMMARY: Heather.E.Achbach@dea.gov or DEA.PRA@dea.gov. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection 1. Type of Information Collection: Revision of a currently approved collection. 2. Title of the Form/Collection: Recordkeeping for Electronic Prescriptions for Controlled Substances. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: No form number is associated with this collection. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Business or other for-profit. Affected public (Other): Not-for-profit institutions; Federal, State, local, and tribal governments. Abstract: DEA is requiring that each registered practitioner apply to an approved credential service provider approved to obtain identity proofing and a credential. Hospitals and other institutional practitioners may conduct this process in-house as part of their credentialing. For practitioners currently working at or affiliated with a registered hospital or clinic, the hospital/clinic have to check a government-issued photographic identification. This may be done when the hospital/clinic issues credentials to new hires or newly affiliated physicians. For individual practitioners, two people need to enter logical access control data to grant permissions for practitioners authorized to approve and sign controlled substance prescriptions using the electronic prescription application. For institutional practitioners, logical access control data is entered by two people from an entity within the hospital/clinic that is separate from the entity that conduct identity proofing in-house. Similarly, pharmacies have to set logical access controls in the pharmacy application so that only authorized employees have permission to annotate or alter prescription records. Finally, if the electronic prescription or pharmacy application generates an incident report, practitioners, hospitals/clinics, and pharmacies have to review the incident report to determine if the event identified by the application represents a security incident. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The DEA estimates that 158,884 registrants participate in this information collection, taking an estimated 40 minutes for Practitioner, 128 minutes for Hospital/Clinic, and 20 minutes for Pharmacy. 6. An estimate of the total public burden (in hours) associated with the proposed collection: DEA estimates that this collection takes 107,733 annual burden hours. 7. An estimate of the total annual cost burden associated with the collection, if applicable: $0. lotter on DSK11XQN23PROD with NOTICES1 TOTAL BURDEN HOURS Number of respondents Activity Frequency Total annual responses Time per response Total annual burden (hours) Practitioner ......................................................................... Hospital/Clinic .................................................................... Pharmacy ........................................................................... 154,571 1,526 2,787 1 1 1 154,571 1,526 2,787 0.67 (40 minutes) ... 2.13 (128 minutes) 0.33 (20 minutes) ... 103,563 1,526 2,787 Unduplicated Totals .................................................... 158,884 N/A 158,884 1.043 ...................... 107,733 VerDate Sep<11>2014 18:03 Nov 25, 2024 Jkt 265001 PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\26NON1.SGM 26NON1 Federal Register / Vol. 89, No. 228 / Tuesday, November 26, 2024 / Notices If additional information is required contact: Darwin Arceo, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, 4W–218, Washington, DC. Dated: November 21, 2024. Darwin Arceo, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2024–27683 Filed 11–25–24; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1121–0339] Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection; Comments Requested: Generic Clearance for Cognitive, Pilot and Field Studies for Bureau of Justice Statistics Data Collection Activities Bureau of Justice Statistics, Department of Justice ACTION: 30-Day notice. AGENCY: The Bureau of Justice Statistics (BJS), Department of Justice (DOJ) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 30 days until December 26, 2024. FOR FURTHER INFORMATION CONTACT: If you have comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Devon Adams, Bureau of Justice Statistics, 999 N Capitol St. NE, Washington, DC 20531 (email: Devon.Adams@usdoj.gov; telephone: 202–307–0765). SUPPLEMENTARY INFORMATION: The proposed information collection was previously published in the Federal Register, volume 89 pages 77545–6, on September 23, 2024. No comments were received. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 18:03 Nov 25, 2024 Jkt 265001 —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Written comments and recommendations for this information collection should be submitted within 30 days of the publication of this notice on the following website www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function and entering either the title of the information collection or the OMB Control Number [1121–0240]. This information collection request may be viewed at www.reginfo.gov. Follow the instructions to view Department of Justice, information collections currently under review by OMB. DOJ seeks PRA authorization for this information collection for three (3) years. OMB authorization for an ICR cannot be for more than three (3) years without renewal. The DOJ notes that information collection requirements submitted to the OMB for existing ICRs receive a month-to-month extension while they undergo review. Abstract: Over the next three years, BJS anticipates undertaking a variety of new surveys and data collections, as well as reassessing ongoing statistical projects, across a number of areas of criminal justice, including law enforcement, courts, corrections, and victimization. This work will entail development of new survey instruments, redesigning and/or modifying existing surveys, procuring administrative data from state and local government entities, and creating or modifying establishment surveys. In order to inform BJS data collection protocols, to develop accurate estimates of respondent burden, and to minimize PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 93349 respondent burden associated with each new or modified data collection, BJS will engage in cognitive, pilot and field test activities to refine instrumentation and data collection methodologies. BJS envisions using a variety of techniques, including but not limited to tests of different types of survey and data collection operations, sample frame development, focus groups, cognitive testing, pilot testing, exploratory interviews, experiments with questionnaire design, and usability testing of electronic data collection instruments. Following standard Office of Management and Budget (OMB) requirements, BJS will submit a change request to OMB individually for every group of data collection activities undertaken under this generic clearance. BJS will provide OMB with a copy of the individual instruments or questionnaires (if one is used), as well as other materials describing the project. Overview of This Information Collection 1. Type of Information Collection: Extension of a currently approved collection. 2. The Title of the Form/Collection: Generic Clearance for cognitive, pilot and field studies for Bureau of Justice Statistics data collection Activities. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: Form numbers not available for generic clearance. The applicable component within the Department of Justice is the Bureau of Justice Statistics, in the Office of Justice Programs. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Administrators or staff of state and local agencies or programs in the relevant fields; administrators or staff of non-government agencies or programs in the relevant fields; individuals; policymakers at various levels of government. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: We estimate that approximately 30,000 respondents will be involved in exploratory, field test, pilot, cognitive, and focus group work conducted under this clearance over the requested 3-year clearance period. The average response time per respondent will be specific to each project covered under the clearance. Specific estimates of the number of respondents and the average response time are not known for each pilot study or development project covered under a generic clearance at this time. Project specific estimates will E:\FR\FM\26NON1.SGM 26NON1

Agencies

[Federal Register Volume 89, Number 228 (Tuesday, November 26, 2024)]
[Notices]
[Pages 93348-93349]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-27683]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0049]


Agency Information Collection Activities; Proposed eCollection 
eComments Requested; Revision Without Change of a Previously Approved 
Collection Recordkeeping for Electronic Prescriptions for Controlled 
Substances

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 60-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will be submitting the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995.

DATES: Comments are encouraged and will be accepted for 60 days until 
January 27, 2025.

FOR FURTHER INFORMATION CONTACT: If you have additional comments 
especially on the estimated public burden or associated response time, 
suggestions, or need a copy of the proposed information collection 
instrument with instructions or additional information, please contact 
Heather E. Achbach, Regulatory Drafting and Policy Support Section, 
Drug Enforcement Administration; Mailing Address: 8701 Morrissette 
Drive, Springfield, Virginia 22152; Telephone: (571) 776-3882; Email: 
[email protected] or [email protected].

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the Bureau of Justice 
Statistics, including whether the information will have practical 
utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

Overview of This Information Collection

    1. Type of Information Collection: Revision of a currently approved 
collection.
    2. Title of the Form/Collection: Recordkeeping for Electronic 
Prescriptions for Controlled Substances.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: No form number is associated 
with this collection. The applicable component within the Department of 
Justice is the Drug Enforcement Administration, Diversion Control 
Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Business or other for-profit.
    Affected public (Other): Not-for-profit institutions; Federal, 
State, local, and tribal governments.
    Abstract: DEA is requiring that each registered practitioner apply 
to an approved credential service provider approved to obtain identity 
proofing and a credential. Hospitals and other institutional 
practitioners may conduct this process in-house as part of their 
credentialing. For practitioners currently working at or affiliated 
with a registered hospital or clinic, the hospital/clinic have to check 
a government-issued photographic identification. This may be done when 
the hospital/clinic issues credentials to new hires or newly affiliated 
physicians. For individual practitioners, two people need to enter 
logical access control data to grant permissions for practitioners 
authorized to approve and sign controlled substance prescriptions using 
the electronic prescription application. For institutional 
practitioners, logical access control data is entered by two people 
from an entity within the hospital/clinic that is separate from the 
entity that conduct identity proofing in-house. Similarly, pharmacies 
have to set logical access controls in the pharmacy application so that 
only authorized employees have permission to annotate or alter 
prescription records. Finally, if the electronic prescription or 
pharmacy application generates an incident report, practitioners, 
hospitals/clinics, and pharmacies have to review the incident report to 
determine if the event identified by the application represents a 
security incident.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
that 158,884 registrants participate in this information collection, 
taking an estimated 40 minutes for Practitioner, 128 minutes for 
Hospital/Clinic, and 20 minutes for Pharmacy.
    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: DEA estimates that this collection takes 
107,733 annual burden hours.
    7. An estimate of the total annual cost burden associated with the 
collection, if applicable: $0.

                                                                   Total Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                           Total annual
                    Activity                        Number of    Frequency    Total annual                Time per response                   burden
                                                   respondents                  responses                                                     (hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Practitioner....................................       154,571            1         154,571  0.67 (40 minutes)..........................         103,563
Hospital/Clinic.................................         1,526            1           1,526  2.13 (128 minutes).........................           1,526
Pharmacy........................................         2,787            1           2,787  0.33 (20 minutes)..........................           2,787
                                                 -------------------------------------------------------------------------------------------------------
    Unduplicated Totals.........................       158,884          N/A         158,884  1.043......................................         107,733
--------------------------------------------------------------------------------------------------------------------------------------------------------


[[Page 93349]]

    If additional information is required contact: Darwin Arceo, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE, 4W-218, Washington, DC.

    Dated: November 21, 2024.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2024-27683 Filed 11-25-24; 8:45 am]
BILLING CODE 4410-09-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.